|
|
Prepublished online as a Blood First Edition Paper on July 10, 2003; DOI 10.1182/blood-2003-03-0727.

Submitted March 7, 2003
Accepted July 1, 2003
Innate CD4+CD25+ regulatory T cells are required for oral tolerance and control CD8+ T cells mediating skin inflammation
Bertrand Dubois, Ludivine Chapat, Anne Goubier, Martine Papiernik, Jean-Francois Nicolas, and Dominique Kaiserlian*
Immunite et Vaccination, INSERM, Unite 404, Lyon, France
INSERM, Unite 345, Paris, France
Immunobiologie fondamentale et clinique, INSERM, Unite 503, Lyon, France
* Corresponding author; email: kaiserlian{at}cervi-lyon.inserm.fr.
To elucidate the role of CD4+CD25+ regulatory T cells in oral tolerance, we used the model of contact hypersensitivity (CHS) to DNFB, which is mediated by CD8+ Tc1 effector cells independently of CD4+ T cell help. Conversely to normal mice, invariant chain KO (Ii°/°) mice, which are deficient in CD4+ T cells, cannot be orally tolerized and develop a chronic hapten-specific CHS response. Transfer of naive CD4+ T cells before hapten gavage into Ii°/° mice restores oral tolerance by a mechanism independent of IL-10 production by CD4+ T cells. That naturally occurring CD4+CD25+ T cells are critical for oral tolerance induction is demonstrated by the finding that: (i) transfer of CD4+CD25+ but not CD4+CD25- T cells into Ii°/° recipients completely prevents the CHS response and skin infiltration by CD8+ T cells, by blocking development of hapten-specific CD8+ T cells, (ii) in vivo depletion of CD4+CD25+ cells by antibody treatment in normal mice impairs oral tolerance and (iii) CD4+CD25+ T cells inhibit hapten-specific CD8+ T cell proliferation and IFN production, in vitro. These data show that naturally occurring CD4+CD25+ T cells are instrumental for orally-induced tolerance and are key actors for the control of antigen-specific CD8+ T cell effectors mediating skin inflammation.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. Hacini-Rachinel, S. Nancey, G. Boschetti, F. Sardi, R. Doucet-Ladeveze, P.-Y. Durand, B. Flourie, and D. Kaiserlian
CD4+ T Cells and Lactobacillus casei Control Relapsing Colitis Mediated by CD8+ T Cells
J. Immunol.,
November 1, 2009;
183(9):
5477 - 5486.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Z. Igyarto, M. C. Jenison, J. C. Dudda, A. Roers, W. Muller, P. A. Koni, D. J. Campbell, M. J. Shlomchik, and D. H. Kaplan
Langerhans Cells Suppress Contact Hypersensitivity Responses Via Cognate CD4 Interaction and Langerhans Cell-Derived IL-10
J. Immunol.,
October 15, 2009;
183(8):
5085 - 5093.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Bowman and M. K. Selgrade
Failure to Induce Oral Tolerance in Mice Is Predictive of Dietary Allergenic Potency among Foods with Sensitizing Capacity
Toxicol. Sci.,
December 1, 2008;
106(2):
435 - 443.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z.-W. Xia, L.-Q. Xu, W.-W. Zhong, J.-J. Wei, N.-L. Li, J. Shao, Y.-Z. Li, S.-C. Yu, and Z.-L. Zhang
Heme Oxygenase-1 Attenuates Ovalbumin-Induced Airway Inflammation by Up-Regulation of Foxp3 T-Regulatory Cells, Interleukin-10, and Membrane-Bound Transforming Growth Factor- 1
Am. J. Pathol.,
December 1, 2007;
171(6):
1904 - 1914.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. Kish, A. V. Gorbachev, and R. L. Fairchild
Regulatory function of CD4+CD25+ T cells from Class II MHC-deficient mice in contact hypersensitivity responses
J. Leukoc. Biol.,
July 1, 2007;
82(1):
85 - 92.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-B. Sun, S. Raghavan, A. Sjoling, S. Lundin, and J. Holmgren
Oral Tolerance Induction with Antigen Conjugated to Cholera Toxin B Subunit Generates Both Foxp3+CD25+ and Foxp3-CD25- CD4+ Regulatory T Cells
J. Immunol.,
December 1, 2006;
177(11):
7634 - 7644.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Gianfrani, M. K. Levings, C. Sartirana, G. Mazzarella, G. Barba, D. Zanzi, A. Camarca, G. Iaquinto, N. Giardullo, S. Auricchio, et al.
Gliadin-Specific Type 1 Regulatory T Cells from the Intestinal Mucosa of Treated Celiac Patients Inhibit Pathogenic T Cells
J. Immunol.,
September 15, 2006;
177(6):
4178 - 4186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Sugimoto, T. Oida, K. Hirota, K. Nakamura, T. Nomura, T. Uchiyama, and S. Sakaguchi
Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis
Int. Immunol.,
August 1, 2006;
18(8):
1197 - 1209.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Carey, A. Allshire, and F. N. van Pelt
Immune Modulation by Cadmium and Lead in the Acute Reporter Antigen-Popliteal Lymph Node Assay
Toxicol. Sci.,
May 1, 2006;
91(1):
113 - 122.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Riemann, K. Loser, S. Beissert, M. Fujita, A. Schwarz, T. Schwarz, and S. Grabbe
IL-12 Breaks Dinitrothiocyanobenzene (DNTB)-Mediated Tolerance and Converts the Tolerogen DNTB into an Immunogen
J. Immunol.,
November 1, 2005;
175(9):
5866 - 5874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P Cobbold
T cell tolerance induced by therapeutic antibodies
Phil Trans R Soc B,
September 29, 2005;
360(1461):
1695 - 1705.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Kaiserlian, N. Cerf-Bensussan, and A. Hosmalin
The mucosal immune system: from control of inflammation to protection against infections
J. Leukoc. Biol.,
August 1, 2005;
78(2):
311 - 318.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Chung, S.-H. Lee, D.-H. Kim, and C.-Y. Kang
Complementary role of CD4+CD25+ regulatory T cells and TGF-{beta} in oral tolerance
J. Leukoc. Biol.,
June 1, 2005;
77(6):
906 - 913.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Z. Mehal, S. Z. Sheikh, L. Gorelik, and R. A. Flavell
TGF-{beta} signaling regulates CD8+ T cell responses to high- and low-affinity TCR interactions
Int. Immunol.,
May 1, 2005;
17(5):
531 - 538.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Alvaro, M. Lejeune, M. T. Salvado, R. Bosch, J. F. Garcia, J. Jaen, A. H. Banham, G. Roncador, C. Montalban, and M. A. Piris
Outcome in Hodgkin's Lymphoma Can Be Predicted from the Presence of Accompanying Cytotoxic and Regulatory T Cells
Clin. Cancer Res.,
February 15, 2005;
11(4):
1467 - 1473.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|